Europe — Total long-lived assets
Geographic · Total long-lived assetsAbbVie Europe — Total long-lived assets increased by 21.5% to $1.80B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 21.5%, from $1.49B to $1.80B.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2017
Last reportedQ4 2025
How to read this metric
An increase typically indicates significant capital investment or acquisitions within the region, while a decrease may suggest asset divestitures, impairment charges, or the depreciation of existing infrastructure.
Detailed definition
This metric represents the total carrying value of non-current, tangible, and intangible assets located within the Europ...
Peer comparison
Peer pharmaceutical companies report similar geographic breakdowns of long-lived assets to demonstrate regional capital intensity and the concentration of manufacturing or R&D infrastructure.
Metric ID:
abbv_segment_europe_total_long_lived_assetsHistorical Data
5 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $1.40B | $1.37B | $1.43B | $1.49B | $1.80B |
| QoQ Change | — | -2.2% | +4.7% | +3.6% | +21.5% |
| YoY Change | — | -2.2% | +4.7% | +3.6% | +21.5% |
Range$1.37B – $1.80B
CAGR+28.9%
Avg YoY Growth+6.9%
Median YoY Growth+4.2%
Current Streak3 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is AbbVie's europe — total long-lived assets?
- AbbVie (ABBV) reported europe — total long-lived assets of $1.80B in Q4 2025.
- How has AbbVie's europe — total long-lived assets changed year-over-year?
- AbbVie's europe — total long-lived assets increased by 21.5% year-over-year, from $1.49B to $1.80B.
- What does europe — total long-lived assets mean?
- The total value of long-term assets, such as facilities and intellectual property, held by the company within its European operations.